Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-22-001838
Filing Date
2022-08-11
Accepted
2022-08-11 15:38:37
Documents
53
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 MYCOTOPIA THERAPIES, INC. - FORM 10-Q SEC FILING tpia-20220630.htm   iXBRL 10-Q 420539
2 CERTIFICATION tpia_ex31z1.htm EX-31.1 6897
3 CERTIFICATION tpia_ex32z1.htm EX-32.1 4567
  Complete submission text file 0001096906-22-001838.txt   2390279

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tpia-20220630_cal.xml EX-101.CAL 18085
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tpia-20220630_def.xml EX-101.DEF 66093
6 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT tpia-20220630_lab.xml EX-101.LAB 146841
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tpia-20220630_pre.xml EX-101.PRE 135422
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tpia-20220630.xsd EX-101.SCH 27887
47 EXTRACTED XBRL INSTANCE DOCUMENT tpia-20220630_htm.xml XML 282151
Mailing Address 480 22ND STREET HEYBURN ID 83336
Business Address 480 22ND STREET HEYBURN ID 83336 208-677-2020
Mycotopia Therapies, Inc. (Filer) CIK: 0001763329 (see all company filings)

EIN.: 870645794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56022 | Film No.: 221155406
SIC: 5141 Wholesale-Groceries, General Line